FDA approves Abbott's AndroGel for hypogonadism treatment in men

[News]

Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.

More... (http://www.news-medical.net/news/20110430/FDA-approves-Abbotts-AndroGel-for-hypogonadism-treatment-in-men.aspx)